These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3916764)

  • 21. Twenty-five years with Cryptococcus neoformans.
    Bulmer GS
    Mycopathologia; 1990 Feb; 109(2):111-22. PubMed ID: 2183062
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW
    Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contemplating the murine test tube: lessons from natural killer cells and Cryptococcus neoformans.
    Marr KJ; Jones GJ; Mody CH
    FEMS Yeast Res; 2006 Jun; 6(4):543-57. PubMed ID: 16696650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity.
    Vecchiarelli A; Casadevall A
    Res Immunol; 1998; 149(4-5):321-33; discussion 500-3. PubMed ID: 9720950
    [No Abstract]   [Full Text] [Related]  

  • 26. An acidic microenvironment increases NK cell killing of Cryptococcus neoformans and Cryptococcus gattii by enhancing perforin degranulation.
    Islam A; Li SS; Oykhman P; Timm-McCann M; Huston SM; Stack D; Xiang RF; Kelly MM; Mody CH
    PLoS Pathog; 2013; 9(7):e1003439. PubMed ID: 23853583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental cryptococcosis in normal and B-cell-deficient mice.
    Monga DP; Kumar R; Mohapatra LN; Malaviya AN
    Infect Immun; 1979 Oct; 26(1):1-3. PubMed ID: 387600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of natural killer cells in resistance to systemic cryptococcosis.
    Salkowski CA; Balish E
    J Leukoc Biol; 1991 Aug; 50(2):151-9. PubMed ID: 2072032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans.
    Hidore MR; Murphy JW
    Infect Immun; 1989 Jul; 57(7):1990-7. PubMed ID: 2659531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of cyclosporine on interleukin-2 receptor expression stimulated by Cryptococcus neoformans.
    Miller GP; Lewis DE
    J Infect Dis; 1987 Apr; 155(4):799-802. PubMed ID: 3102632
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice.
    Lipscomb MF; Alvarellos T; Toews GB; Tompkins R; Evans Z; Koo G; Kumar V
    Am J Pathol; 1987 Aug; 128(2):354-61. PubMed ID: 3618730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host immunity to Cryptococcus neoformans.
    Rohatgi S; Pirofski LA
    Future Microbiol; 2015; 10(4):565-81. PubMed ID: 25865194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.
    Mody CH; Lipscomb MF; Street NE; Toews GB
    J Immunol; 1990 Feb; 144(4):1472-7. PubMed ID: 1968080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.
    Levitz SM; Dupont MP; Smail EH
    Infect Immun; 1994 Jan; 62(1):194-202. PubMed ID: 8262627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β1 Integrins Are Required To Mediate NK Cell Killing of
    Xiang RF; Li S; Ogbomo H; Stack D; Mody CH
    J Immunol; 2018 Oct; 201(8):2369-2376. PubMed ID: 30201811
    [No Abstract]   [Full Text] [Related]  

  • 37. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.
    Kawakami K; Koguchi Y; Qureshi MH; Miyazato A; Yara S; Kinjo Y; Iwakura Y; Takeda K; Akira S; Kurimoto M; Saito A
    J Immunol; 2000 Jul; 165(2):941-7. PubMed ID: 10878369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.
    Anderson DM; Dykstra MA
    Mycopathologia; 1984 Jun; 86(3):169-77. PubMed ID: 6382015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 40. Murine natural killer cells are fungicidal to Cryptococcus neoformans.
    Hidore MR; Nabavi N; Sonleitner F; Murphy JW
    Infect Immun; 1991 May; 59(5):1747-54. PubMed ID: 1708359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.